- Oops!Something went wrong.Please try again later.
Former Best Buy CEO Hubert Joly told Yahoo Finance what he learned while rebuilding Best Buy and how retailers can learn from his experience.
Former Best Buy CEO Hubert Joly told Yahoo Finance what he learned while rebuilding Best Buy and how retailers can learn from his experience.
The highway patrol report did not say whether the Tesla was operating on Autopilot, its semi-autonomous driving system, when the crash occurred at about 2:40 a.m. Wednesday. The 50-year-old truck driver and the 30-year-old motorist who stopped to help him both sustained major injuries, the police report said. The 35-year-old man driving the Tesla was not identified in the report.
Bengaluru (Karnataka) [India], May 6 (ANI): The Karnataka High Court has directed the Centre to immediately increase the cap on allocation of liquid medical oxygen (LMO) to the state of Karnataka to 1200 MT per day amid the COVID-19 crisis.
CALGARY, Alberta, May 05, 2021 (GLOBE NEWSWIRE) -- Badger Infrastructure Solutions Ltd. (formerly Badger Daylighting Ltd) (“Badger” or “the Company”) announced that all of the motions put forward at its annual and special meeting of shareholders held on May 5, 2021 (the “Meeting”) were approved by shareholders. Pursuant to the requirements of the Toronto Stock Exchange, the Company is issuing this news release to summarize the voting results in respect of the Meeting. A total of 28,985,741 common shares of the Company, representing approximately 83.16% of the outstanding common shares, were represented in person or by proxy at the Meeting. The nine director nominees proposed by management were elected by ballot at the Meeting. Proxies and in person votes were received as follows: Votes For% Votes Withheld% Glen Roane27,846,20296.28%1,075,8103.72%Catherine Best28,075,64497.07%846,3682.93%Grant Billing27,236,09694.17%1,685,9165.83%David Bronicheski28,653,11899.07%268,8940.93%William Derwin28,765,06899.46%156,9440.54%Stephen Jones28,917,46299.98%4,5500.02%Mary Jordan28,602,32698.89%319,6861.11%William Lingard28,562,92498.76%359,0881.24%Paul Vanderberg28,915,68099.98%6,3320.02% Further, of the proxies and in person votes received 96.52% voted in favour of management’s approach to executive compensation (say on pay) as disclosed in the management proxy circular dated March 30, 2021. In addition, of the proxies and in person votes received 89.91% voted in favour of appointing Deloitte LLP as the Company’s auditors, 91.21% voted in favour of By-Law No.1 and 98.80% voted in favour of the name change from Badger Daylighting Ltd. to Badger Infrastructure Solutions Ltd. About Badger Infrastructure Solutions Ltd. Badger Infrastructure Solutions Ltd. (TSX:BAD) is North America’s largest provider of non-destructive excavating services. Badger works for contractors and facility owners in a broad range of infrastructure industries. These market segments consist primarily of infrastructure projects in areas such as energy generation, electricity and natural gas transmission networks, roads and highways, telecommunications, water and sewage treatment and general municipal infrastructure. Customers in these segments typically operate near high concentrations of underground power, communication, water, gas and sewer lines, particularly in large urban centres where safety and economic risks are high and therefore non-destructive excavation provides a safe alternative for certain customer excavation requirements. The Company’s key technology is the Badger Hydrovac™, which is used primarily for safe excavation around critical infrastructure and in congested underground conditions. The Badger Hydrovac uses a pressurized water stream to liquefy the soil cover, which is then removed with a powerful vacuum system and deposited into a storage tank. Badger manufactures and designs its truck-mounted hydrovac units, giving Badger the opportunity to incorporate feedback from its hydrovac operators into its existing and future design and manufacturing processes. For further information:Paul Vanderberg, President and CEO Darren Yaworsky, Vice President, Finance and CFOPramod Bhatia, Vice President, Strategic Planning and Investor Relations Badger Infrastructure Solutions Ltd.ATCO Centre IISuite 400, 919 - 11th Avenue SWCalgary, Alberta T2R 1P3Telephone (403) 264-8500Fax (403) 228-9773 Source: Badger Infrastructure Solutions Ltd.
Couple had broken up after he gave her the final rose following news of her attending antebellum sorority party in college.
Hyperion Metals Limited (ASX: HYM) ("Hyperion" or "the Company") is pleased to provide an update on the progress of the Company’s bulk test work and Phase 3 drilling program from its Titan critical mineral project ("Titan Project"), in Tennessee, USA.
A proposed golf 'Super League' is largely meeting a similar reception to its flaming failure soccer counterpart.
American Tower Corporation (NYSE: AMT) today announced the pricing of its registered public offering of 9,000,000 shares of common stock at $244.75 per share. The offering was upsized from the previously announced offering size of 8,500,000 shares. The underwriters of the offering have an option to purchase up to an additional 900,000 shares of common stock to cover over-allotments, if any. The net proceeds of the offering are expected to be approximately $2,147.1 million (or approximately $2,361.8 million if the underwriters exercise their option to purchase additional shares in full) after deducting underwriting discounts and estimated offering expenses. American Tower expects to use the net proceeds from this offering, together with cash on hand and borrowings under its revolving credit facilities and term loans, to finance the recently announced Telxius transaction and to pay related fees and expenses. If for any reason the Telxius transaction is not completed, American Tower expects to use the net proceeds from these offerings to repay existing indebtedness and for general corporate purposes.
Judith Collins’ comments on Māori health policy are a diversion . National leader’s warning about greater Māori self-governance are designed to deflect from her unpopularity
Skywatchers in Washington were mesmerized by a string of lights in the evening sky on May 4, local media said, which were determined to be Starlink satellites launched by SpaceX earlier that day.This clip from Daffa Azizan shows the satellites in the sky over Lynnwood, Washington.“What the hell is that,” Azizan says in the video. “Some weird UFO-esque thing in the sky tonight over Lynnwood, Washington. I really thought it was santa lol this is scaring me” he wrote in his Twitter post.SpaceX said 60 satellites were launched on Tuesday from the Kennedy Space Center in Florida. Credit: Daffa Azizan via Storyful
Former president threatens ‘corrupt social media companies’ will pay political price
Hyderabad (Telangana) [India], May 6 (ANI): Bharatiya Janata Party (BJP) leader NV Subhash on Wednesday accused Chief Minister K Chandrasekhar Rao (KCR) of utilising official state machinery against minister Etela Rajender, and said that he had stopped to the level of a 'gully leader'.
Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today a retail collaboration with Walgreens to make Quidel’s non-prescription QuickVue® At-Home OTC COVID-19 Test available to consumers at 7,600 Walgreens locations across the United States and Puerto Rico. The shelf-stable packages, each containing two of the self-administered rapid antigen tests, can also be ordered online at Walgreens.com for store pick-up or same day delivery.
Congresswoman says that GOP at ‘turning point’ over ex-president’s 2020 election lies
Paul DeJong hit a tworun homer, Paul Goldschmidt added a solo shot off Marcus Stroman and the St. Louis Cardinals beat the New York Mets 41 in a doubleheader opener on Wednesday that extended their winning streak to six.
"We are selling the very first seat on New Shepherd, and that flight will take place on July 20th of this year." Blue Origin on Wednesday opened bidding for one single civilian seat aboard its first crew flight into spaceon July 20 that it promised would be a “spectacular” suborbital trip -- marking what would be a landmark moment in the race for private commercial space travel. Billionaire Jeff Bezos’ rocket company said one seat will go to a winning bidder of a five-week sealed online auction, with proceeds donated to the space firm's foundation. But the company’s Director of Astronaut Sales Ariane Cornell was silent about the details of the future ticket prices -- a closely guarded secret inside the company for years. Reuters reported in 2018 that Blue Origin was planning to charge passengers at least $200,000 for the ride. Cornell, however,did offer a glimpse of what that lucky bidder can expect to experience on July 20th if all goes according to plan. "The capsule sits on top of the New Shepard booster. The two lift off together, the booster pushing up the capsule up toward space. We aim for an altitude of 105 kilometers, about 350,000 feet up. That's about 10 times the altitude of what you fly in a commercial airline. Now, as the rocket and the booster, excuse me the booster and the capsule lift off, they accelerate to about MACH3, the astronauts experience about three GS. In fact, it's quite comfortable in those reclining seats that you just saw. And then at about seventy-five kilometers, or about 250,000 feet, the two vehicle separate. And that's when the astronauts start to feel their zero GS. That's when we're going to let them unbuckle, take in the three minutes or so of Zero Gs." …That’s whenBlue Origin saysthey’re expected to experience weightlessness and see the curvature of the planet before the pressurized capsule returns to earth under parachutes. The capsule’s six observation windows are the largest ever used in space. After its first flight in July, Cornell said Blue Origin would have "a couple more" crewed flights before the end of the year. It’s unclear if Mr. Bezos himself will take a flight, unlike Richard Branson, who plans to be aboard rival Virgin Galactic’s first flight later this year… with plans for Branson’s company to fly private customers in early 2022.
The governor has said he will sign the bill, which is meant to address a shortage in lethal injection drugs
The Biden administration plans to release by the end of June a list of corrupt Central American officials who may be subject to sanctions, a U.S. special envoy told Reuters, as Washington seeks to cut back on a root cause of increased migration to the U.S.Mexican border.
A Brazilian judge on Wednesday suspended a police probe into a top Indigenous leader who had criticized the government of President Jair Bolsonaro for its handling of the COVID19 crisis, which has had a devastating impact on native peoples.
Out of all T-cell Leukemia pipeline therapies, HBI-8000 is set to capture the maximum patient pool owing to its immunomodulatory function.Los Angeles, USA, May 05, 2021 (GLOBE NEWSWIRE) -- T-cell Leukemia Pipeline: Comprehensive Analysis of 15+ Key Players and 15+ Key Therapies Out of all T-cell Leukemia pipeline therapies, HBI-8000 is set to capture the maximum patient pool owing to its immunomodulatory function. DelveInsight’s ‘T-cell Leukemia Pipeline Insights’ report provides a holistic view of the pipeline therapies that are under development in pre-clinical as well as clinical stages of development, and growth prospects across the T-cell Leukemia domain. Some of the key highlights of the T-cell Leukemia Pipeline report: T-cell Leukemia Pipeline report offers a comprehensive analysis of 15+ key players and 15+ key therapies.Out of all the emerging therapies, HBI-8000 is expected to capture the maximum patient pool owing to its immunomodulatory function. This oral agent targets class I histone deacetylase causing cell cycle arrest and tumor cell death as the mechanism underlying its single-agent activity against lymphoma.T-cell Leukemia pipeline comprises ASTX 660 (Otsuka Pharmaceutical) is in phase I/II while Valemetostat and Brentuximab vedotin (Seagen/Takeda) is in Phase II stage of development. HUYA Bioscience appears to have an upper edge as its therapy, HBI-8000 which is in the pre-registration phase. In April 2021, Shorla Pharma announced that the U.S. Food and Drug Administration (FDA) has accepted the filing application of its oncology drug SH-111 which is designed to treat T-cell Leukemia. Got queries? Want to know more? Request for Sample @ T-cell Leukemia Emerging Therapies and Forecast The report lays down a complete coverage of the therapeutics by development stage, product type, and route of administration, molecule type, and MOA type for T-cell Leukemia across the complete product development cycle, including all clinical and non-clinical stages. The T-cell Leukemia pipeline report puts on the table business opportunities, threats, prospective collaborations, strong competitors, growth strategies, and failed as well as discontinued drugs. T-cell Leukemia Pipeline Drugs DrugCompanyClinical PhaseMoARoAValemetostatDaiichi SankyoPhase IIHistone-lysine N-methyltransferase inhibitorsOralBNZ-1BionizPhase IIInterleukin receptor antagonistsIntravenousASTX 660Otsuka PharmaceuticalPhase I/IIInhibitor of apoptosis protein inhibitors; OralBrentuximab vedotinSeagen /TakedaPhase IIApoptosis stimulantsIntravenousHBI-8000HUYA BiosciencePreregistrationRas protein inhibitorsOral Request for Sample to know more @ T-cell Leukemia Pipeline Analysis, Key Companies and Futuristic Trends T-cell Leukemia Therapeutic Assessment The T-cell Leukemia Pipeline report proffers exhaustive insights into active pipeline assets segmented by Stage, Product Type, Route of Administration, Molecule Type, Target, and Indications of various drugs. By Product Type MonoCombination By Stage Discovery Pre-clinicalINDPhase IPhase IIPhase IIIPre-registration By Molecule Type Small Molecule Gene TherapyStem Cell Therapy By Route of Administration IntravenousInhalationOralSubcutaneous By Mechanism of Action Enhancer of zeste homolog 1 and 2 protein inhibitorsHistone-lysine N-methyltransferase inhibitorsInterleukin 15 receptor antagonistsInterleukin 2 receptor antagonistsInterleukin 9 receptor antagonists1 Phosphatidylinositol 3 kinase inhibitors HDAC 1,2,3, and 10 protein inhibitorsMitogen-activated protein kinase inhibitors By Targets Protease Multiple Kinase Interleukin 15 receptorInterleukin 2 receptor Interleukin 9 receptorHistone-lysine N-methyltransferase Get in touch with our Business executive for Rich and Deep Market Assessment and Consulting Solutions Scope of the Report Coverage: GlobalKey Players: Daiichi Sankyo; Bioniz; Otsuka Pharmaceutical; Seagen /Takeda; HUYA Bioscience; iCell Gene Therapeutics; Gracell Biotechnology; Ascentage Pharma Group; Celgene Corporation; Shorla Pharma; AVM Biotechnology; Expression Therapeutics; miRagen Therapeutics, and others.Key T-cell Leukemia Pipeline Therapies: Valemetostat; BNZ-1; ASTX 660; Brentuximab vedotin; HBI-8000; CD4CAR; CD7 UCAR-T cells; APG-115; Romidepsin; SH-111; Cobomarsen; AVM-0703, and others. Reach out @ T-cell Leukemia Pipeline: Novel therapies and emerging technologies Table of Contents 1Introduction2Executive Summary3T-cell Leukemia Overview4T-cell Leukemia Pipeline Therapeutics5T-cell Leukemia Pipeline Therapeutic Assessment6T-cell Leukemia – DelveInsight’s Analytical Perspective7In-depth Commercial T-cell Leukemia Pipeline Assessment8T-cell Leukemia Collaboration Deals9Late Stage T-cell Leukemia Pipeline Products (Phase III and Preregistration)10Mid-Stage T-cell Leukemia Pipeline Products (Phase II)11Pre-clinical and Discovery Stage T-cell Leukemia Pipeline Products12Inactive T-cell Leukemia Pipeline Products13T-cell Leukemia Key Companies14T-cell Leukemia Key Products15T-cell Leukemia Unmet Needs16T-cell Leukemia Market Drivers and Barriers17T-cell Leukemia Future Perspectives and Conclusion18T-cell Leukemia Pipeline Analyst Views20Appendix Visit to know more of what’s covered @ T-cell Leukemia Emerging Therapies Browse through Related Reports CAR T-Cell Therapy for Acute Lymphoblastic LeukemiaDelveInsight’s “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL)- Market Insights and Market Forecast- 2030” report. CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Pipeline DelveInsight’s, “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Acute Lymphoblastic Leukemia pipeline landscape. Adult T Cell Leukemia Lymphoma MarketDelveInsight's "Adult T-Cell Leukemia-Lymphoma - Market Insights, Epidemiology, and Market Forecast-2030" report. Acute Myeloid Leukemia MarketDelveInsight's "Acute Myeloid Leukemia (AML) Market Insights, Epidemiology, and Market Forecast-2030" report. B-Cell Chronic Lymphocytic Leukemia MarketDelveInsight's "B-Cell Chronic Lymphocytic Leukemia - Market Insights, Epidemiology, and Market Forecast-2030" report. Hairy Cell Leukemia Market Insight Epidemiology and Market ForecastDelveInsight's 'Hairy Cell Leukemia (HCL)- Market Insights, Epidemiology and Market Forecast-2028' report. Bowens Disease MarketDelveInsight's "Bowen's Disease - Market Insights, Epidemiology, and Market Forecast-2030" report. Buergers Disease MarketDelveInsight's "Buerger’s Disease - Market Insights, Epidemiology, and Market Forecast-2030" report. Brucellosis MarketDelveInsight's "Brucellosis - Market Insights, Epidemiology, and Market Forecast-2030" report. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. For more insights, visit Pharma, Healthcare, and Biotech News CONTACT: Shruti Thakur firstname.lastname@example.org +1(919)321-6187 www.delveinsight.com
Amaravati (Andhra Pradesh) [India], May 6 (ANI): As part of the partial curfew and Section 144 imposed in Andhra Pradesh, the Srikakulam district police on Wednesday held a COVID-19 awareness rally with 10 vehicles in all major junctions of the town.